ISARIC coronavirus clinical characterisation consortium

C. Semple (Liverpool, United Kingdom)

Source: ERS Course 2021 - COVID-19: State of the art
Number: 33

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Semple (Liverpool, United Kingdom). ISARIC coronavirus clinical characterisation consortium. ERS Course 2021 - COVID-19: State of the art

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Features of the clinical course of coronavirus and bacterial pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Applying clinical metagenomics for the detection and characterisation of respiratory infections
Source: Eur Respir Monogr 2019; 83: 35-49
Year: 2019


Historical perspective: other human coronavirus infectious diseases, SARS and MERS
Source: Eur Respir Monogr 2021; 94: 28-38
Year: 2021


Update on respiratory virus research and clinical care including influenza outbreak 2017-18, SARS, MERS and other respiratory pathogens
Source: International Congress 2018 – PG3 How to plan for and manage a respiratory epidemic/pandemic
Year: 2018


Drug repurposing and other strategies for rapid coronavirus antiviral development: lessons from the early stage of the COVID-19 pandemic
Source: Eur Respir Monogr 2021; 94: 39-68
Year: 2021


ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies
Source: Virtual Congress 2020 – New developments in pandemic medicine
Year: 2020


Impact of the novel coronavirus (COVID-19) pandemic on sleep
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Assessment of knowledge, attitude and practice towards 2019 novel coronavirus.
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020


RT-PCR microarray detection of viral respiratory pathogens demonstrates the major role of human metapneumovirus and human rhinovirus in acute exacerbations of COPD in France
Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Year: 2010


Coronavirus disease: outbreak in China and globally
Source: Webinar 2020
Year: 2020

Interview on Coronavirus COVID-19 management experience in China
Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China
Year: 2020

Sporadic coronavirus and human metapneumovirus lower respiratory tract infection in adults: comparison of chest CT findings and correlation with clinical outcomes
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020


Strategies for the prevention and management of coronavirus disease 2019
Source: Eur Respir J, 55 (4) 2000597; 10.1183/13993003.00597-2020
Year: 2020



Pathogenetic treatment of patients with new coronavirus infection COVID-19
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021


Perspectives of the management of COVID-19 infection in China
Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China
Year: 2020

Development and characterisation of a multi-species COPD biofilm
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


Respiratory syncytial virus and metapneumovirus in Brazilian infants: PCR, genotypes and clinical data
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008

SIPS Project: A tool for the detection of human and non-human strains of influenza A in Kentucky
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010

Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020